BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

The performance of 1H19 IPOs point toward a continuation of a dual-class system where biotechs backed by deep-pocketed VCs and crossover investors can tap the public market at will and generate stronger after-market performance than...
BioCentury | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

...2015-09-08 Type: Venture financing Raised: $12 million Investors: Golden Seeds LLC; Bios Memory; Cowtown Angels; Scale Investors...
BioCentury | Sep 1, 2008
Finance

Ebb & Flow

...the initial marketing effort for HealthShares was too retail-oriented and should have been focused on larger-scale investors...
Items per page:
1 - 3 of 3
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

The performance of 1H19 IPOs point toward a continuation of a dual-class system where biotechs backed by deep-pocketed VCs and crossover investors can tap the public market at will and generate stronger after-market performance than...
BioCentury | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

...2015-09-08 Type: Venture financing Raised: $12 million Investors: Golden Seeds LLC; Bios Memory; Cowtown Angels; Scale Investors...
BioCentury | Sep 1, 2008
Finance

Ebb & Flow

...the initial marketing effort for HealthShares was too retail-oriented and should have been focused on larger-scale investors...
Items per page:
1 - 3 of 3